Volatile agents and nitrous oxide: when and when not

Why examiners ask this

The examiner uses this topic to check that you know what the vapor is doing to the patient in front of you, not just its MAC. Questions arrive sideways: "would you use nitrous here?", "why sevoflurane and not desflurane?", "what does the volatile do to her uterus?" It tests application of knowledge and judgment, and the contraindications to nitrous are a favorite source of quick points won or lost.

The 60-second answer

Decision points and the "why"

• Sevoflurane vs. desflurane — desflurane has the lowest blood-gas solubility (0.42 vs. 0.65–0.69 for sevoflurane),¹ so emergence is faster after long cases and in obesity. Its pungency causes coughing and laryngospasm, the label contraindicates it for inhalational induction in children, and a rapid increase in concentration produces a marked rise in heart rate.²
• Compound A and fresh gas flow — sevoflurane degrades in CO2 absorbents; the label does not recommend flows below 1 L/min and limits exposure at 1 to <2 L/min to 2 MAC-hours, so beyond that I run 2 L/min.³ Calcium hydroxide absorbents that do not form compound A are why many departments now run lower flows.
• Desiccated absorbent — desflurane with dry absorbent produces carbon monoxide;² sevoflurane can generate extreme heat, smoke and fire in the circuit.³ I change absorbent left with oxygen flowing over a weekend.
• Cerebral effects — above about 1 MAC, volatiles uncouple flow from metabolism and raise intracranial pressure; the desflurane label notes a dose-dependent rise in CSF pressure.² With a tight brain I keep below 1 MAC or switch to propofol.
• Neuromonitoring — volatiles depress motor evoked potentials more than SSEPs; I use TIVA for MEP cases and keep volatile at 0.5 MAC or less if I use any.
• Uterine tone — volatiles relax the uterus dose-dependently; useful for retained placenta, harmful after delivery at cesarean. I keep below 0.5–0.75 MAC once the baby is out.
• Nitrous contraindications — it is about 34 times more soluble in blood than nitrogen, so it enters closed air spaces faster than nitrogen can leave: pneumothorax, bowel obstruction, pneumocephalus, tympanic membrane grafting, intraocular gas (SF6 or C3F8) within weeks of retinal surgery, pulmonary air cysts, and venous air embolism.¹ It raises pulmonary vascular resistance and inactivates vitamin B12, reducing methionine synthase activity,¹ which matters in B12 deficiency and MTHFR deficiency.

The complication they will inject

During a laparoscopic hernia repair under sevoflurane and 60% nitrous, the surgeon says the bowel is distended and the airway pressure climbs as the abdomen tightens. I turn nitrous off, because it is expanding gas in the bowel and the peritoneal space, and increase oxygen with air. I tell the surgeon why and ask them to reduce insufflation pressure while I deepen with volatile. I check the airway pressure trace and listen to the chest, because a sudden rise could equally be a capnothorax; if the SpO2 falls and one side is silent, I tell the surgeon to desufflate. Then I reassess: once the bowel decompresses the case proceeds without nitrous.

Pitfalls that cost points

• Reciting MAC values without connecting them to a decision.
• Forgetting the eye with intraocular gas; the nitrous can cause blindness through central retinal artery occlusion.
• Using desflurane for a mask induction.
• Ignoring the environmental cost: ASA guidance tells providers to avoid agents with disproportionate climate impact (desflurane's potency-scaled warming potential is about 40–50 times sevoflurane's) and to use the lowest possible fresh gas flow.⁴
• Treating a lightening of anesthesia with nitrous alone; at 1 atmosphere it cannot reach 1 MAC (MAC 104%).

Rapid-why

Q: Why does nitrous speed the uptake of a second gas? A: Its large-volume uptake concentrates the remaining alveolar gases and draws in more inspired gas, the second-gas and concentration effects.

Q: What is diffusion hypoxia? A: At the end of a nitrous anesthetic, large volumes of nitrous leave blood for the alveoli and dilute oxygen; I give 100% oxygen for several minutes after turning it off.

Q: Which volatile is best for a patient with coronary disease? A: Any of them at stable concentrations; what matters is avoiding tachycardia and hypotension, so I avoid rapid desflurane increases.

Q: Why avoid volatiles in Duchenne dystrophy? A: They can cause rhabdomyolysis and hyperkalemia even without succinylcholine, so I use TIVA.

Numbers to know

Links

• Malignant hyperthermia, Raised intracranial pressure: evaluation and reduction, ponv, Venous air embolism and the sitting position, Neuromonitoring: SSEPs, MEPs and anesthetic choice (coming), laparoscopy
• ASA statement on the use of nitrous oxide and environmental sustainability in anesthesiology